Advance and cogitation of gene therapy for Duchenne muscular dystrophy

Duchenne muscular dystrophy (DMD) is the common hereditary muscular disease caused by the deficiency of cytoskeletal protein dystrophin on the sarcolemma. It is characterized by progessive muscle weakness and atrophy and dying of heart or respiratory failure. Currently the gene therapy strategies of...

Full description

Bibliographic Details
Main Authors: Cheng ZHANG, Jin-fu LIN, Zi-yu LIAO
Format: Article
Language:English
Published: Tianjin Huanhu Hospital 2019-05-01
Series:Chinese Journal of Contemporary Neurology and Neurosurgery
Subjects:
Online Access:http://cjcnn.org/index.php/cjcnn/article/view/1951
_version_ 1818025563902705664
author Cheng ZHANG
Jin-fu LIN
Zi-yu LIAO
author_facet Cheng ZHANG
Jin-fu LIN
Zi-yu LIAO
author_sort Cheng ZHANG
collection DOAJ
description Duchenne muscular dystrophy (DMD) is the common hereditary muscular disease caused by the deficiency of cytoskeletal protein dystrophin on the sarcolemma. It is characterized by progessive muscle weakness and atrophy and dying of heart or respiratory failure. Currently the gene therapy strategies of DMD can be catagorized into two groups: restoring dystrophin expression and compensating for the lack of dystrophin. Therapies restoring dystrophin include nonsense mutation readthrough, exon skipping, adeno-associated virus (AAV) mediated micro-dystrophin therapy and gene editing. Here we summarize the latest advance of gene therapy for DMD, focusing on strategies that restore dystrophin, hoping to benefit the choosing of optimal gene therapy. DOI: 10.3969/j.issn.1672-6731.2019.05.004
first_indexed 2024-12-10T04:18:06Z
format Article
id doaj.art-56e37e6c19d54108817654861c4f3c9d
institution Directory Open Access Journal
issn 1672-6731
language English
last_indexed 2024-12-10T04:18:06Z
publishDate 2019-05-01
publisher Tianjin Huanhu Hospital
record_format Article
series Chinese Journal of Contemporary Neurology and Neurosurgery
spelling doaj.art-56e37e6c19d54108817654861c4f3c9d2022-12-22T02:02:30ZengTianjin Huanhu HospitalChinese Journal of Contemporary Neurology and Neurosurgery1672-67312019-05-011953123191906Advance and cogitation of gene therapy for Duchenne muscular dystrophyCheng ZHANG0Jin-fu LIN1Zi-yu LIAO2Department of Neurology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong, ChinaDepartment of Neurology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong, ChinaDepartment of Neurology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong, ChinaDuchenne muscular dystrophy (DMD) is the common hereditary muscular disease caused by the deficiency of cytoskeletal protein dystrophin on the sarcolemma. It is characterized by progessive muscle weakness and atrophy and dying of heart or respiratory failure. Currently the gene therapy strategies of DMD can be catagorized into two groups: restoring dystrophin expression and compensating for the lack of dystrophin. Therapies restoring dystrophin include nonsense mutation readthrough, exon skipping, adeno-associated virus (AAV) mediated micro-dystrophin therapy and gene editing. Here we summarize the latest advance of gene therapy for DMD, focusing on strategies that restore dystrophin, hoping to benefit the choosing of optimal gene therapy. DOI: 10.3969/j.issn.1672-6731.2019.05.004http://cjcnn.org/index.php/cjcnn/article/view/1951Muscular dystrophy, DuchenneGenetic therapyReview
spellingShingle Cheng ZHANG
Jin-fu LIN
Zi-yu LIAO
Advance and cogitation of gene therapy for Duchenne muscular dystrophy
Chinese Journal of Contemporary Neurology and Neurosurgery
Muscular dystrophy, Duchenne
Genetic therapy
Review
title Advance and cogitation of gene therapy for Duchenne muscular dystrophy
title_full Advance and cogitation of gene therapy for Duchenne muscular dystrophy
title_fullStr Advance and cogitation of gene therapy for Duchenne muscular dystrophy
title_full_unstemmed Advance and cogitation of gene therapy for Duchenne muscular dystrophy
title_short Advance and cogitation of gene therapy for Duchenne muscular dystrophy
title_sort advance and cogitation of gene therapy for duchenne muscular dystrophy
topic Muscular dystrophy, Duchenne
Genetic therapy
Review
url http://cjcnn.org/index.php/cjcnn/article/view/1951
work_keys_str_mv AT chengzhang advanceandcogitationofgenetherapyforduchennemusculardystrophy
AT jinfulin advanceandcogitationofgenetherapyforduchennemusculardystrophy
AT ziyuliao advanceandcogitationofgenetherapyforduchennemusculardystrophy